Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083318
Filing Date
2025-06-06
Accepted
2025-06-06 17:57:58
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5972
  Complete submission text file 0000950170-25-083318.txt   7405
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Cannon Gillian (Reporting) CIK: 0001833910 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 251032306